SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
HNI Corporation (HNI) trades at a trailing P/E of 29.5, forward P/E of 10.2. Trailing earnings yield is 3.39%, forward earnings yield 9.80%. PEG 0.05 (Peter Lynch undervalued ≤1.0). Graham Number is $32.35.
Criteria proven by this page:
- VALUE (70/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.05); analyst target implies upside (+162%).
- Forward P/E 10.2 (down from trailing 29.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.05 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 3.39% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 9.80% as earnings recover.
- Analyst consensus target $95.00 (+162% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 68/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
70/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HNI
Valuation Multiples
P/E (TTM)29.5
Forward P/E10.2
PEG Ratio0.05
Forward PEG0.05
P/B Ratio0.87
P/S Ratio0.58
EV/EBITDA11.3
Per Share Data
EPS (TTM)$1.17
Forward EPS (Est.)$3.56
Book Value / Share$39.73
Revenue / Share$61.45
FCF / Share$4.55
Yields & Fair Value
Earnings Yield3.39%
Forward Earnings Yield9.80%
Dividend Yield3.94%
Graham Number$32.35
SharesGrow IV$194.50 (+436.4%)
Analyst Target$95.00 (+162%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
29.0 |
-1.53 |
4.96 |
1.13 |
1.95% |
| 2017 |
18.8 |
3.03 |
3.29 |
0.78 |
2.93% |
| 2018 |
16.6 |
3.77 |
2.75 |
0.68 |
3.30% |
| 2019 |
14.6 |
0.74 |
2.76 |
0.72 |
3.24% |
| 2020 |
35.1 |
-0.57 |
2.49 |
0.75 |
3.54% |
| 2021 |
30.5 |
0.75 |
3.10 |
0.84 |
2.94% |
| 2022 |
9.6 |
0.08 |
1.92 |
0.50 |
4.49% |
| 2023 |
37.8 |
-0.60 |
2.44 |
0.76 |
3.14% |
| 2024 |
17.3 |
0.10 |
2.87 |
0.95 |
2.64% |
| 2026 |
37.6 |
-0.61 |
1.11 |
0.72 |
3.09% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$2.54 |
$2.25B |
$110.51M |
4.9% |
| 2020 |
$0.98 |
$1.96B |
$41.9M |
2.1% |
| 2020 |
$0.98 |
$1.96B |
$41.9M |
2.1% |
| 2021 |
$1.36 |
$2.18B |
$59.8M |
2.7% |
| 2021 |
$1.36 |
$2.18B |
$59.8M |
2.7% |
| 2022 |
$2.94 |
$2.36B |
$123.9M |
5.2% |
| 2023 |
$1.08 |
$2.43B |
$49.2M |
2% |
| 2023 |
$1.08 |
$2.43B |
$49.2M |
2% |
| 2024 |
$2.88 |
$2.53B |
$139.5M |
5.5% |
| 2025 |
$1.11 |
$2.84B |
$54.2M |
1.9% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$3.56 |
$3.53 – $3.57 |
$2.66B |
$2.65B – $2.67B |
3 |
| 2027 |
$4.11 |
$4.04 – $4.18 |
$6.13B |
$6.08B – $6.15B |
2 |
| 2028 |
$4.83 |
$4.78 – $4.89 |
$6.37B |
$6.33B – $6.44B |
2 |
| 2029 |
$5.60 |
$5.55 – $5.68 |
$6.84B |
$6.84B – $6.84B |
1 |
| 2030 |
$6.25 |
$6.20 – $6.34 |
$7.2B |
$7.15B – $7.27B |
1 |
